Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/1999
11/09/1999CA1340815C Hybridomas producing monoclonal antibodies to new mucin epitopes
11/04/1999WO1999056129A1 Methods of selecting internalizing antibodies
11/04/1999WO1999055876A2 Polypeptide with immunogenic properties and with a protein with modified biological functions
11/04/1999WO1999055875A2 VACCINES CONTAINING RECOMBINANT PILIN AGAINST NEISSERIA GONORRHOEAE OR $i(NEISSERIA MENINGITIDIS)
11/04/1999WO1999055874A2 Nucleic acids of the m antigen gene of histoplasma capsulatum, antigens, vaccines and antibodies, methods and kits for detecting histoplasmosis
11/04/1999WO1999055873A2 Basb006 polynucleotide(s) and polypeptides from neisseria meningitis
11/04/1999WO1999055872A1 Basb013 dna and proteins from neisseria meningitidis
11/04/1999WO1999055871A1 Polypeptides from moraxella (branhamella) catarrhalis
11/04/1999WO1999055868A2 Fizz proteins
11/04/1999WO1999055860A1 Host-encoded protein expressed on marek's disease (mdv)-infected cells and antibody thereto
11/04/1999WO1999055849A1 Tyrosine phosphatase ia-2, gad and rotavirus vp7 immunity
11/04/1999WO1999055735A1 G-csf receptor agonist antibodies and screening method therefor
11/04/1999WO1999055730A2 Polyepitope carrier protein
11/04/1999WO1999055715A2 Polysaccharide-antigen conjugates
11/04/1999WO1999055381A1 Method and process for establishment of stage specific expression and characterization of proteins based on microbial or human genomic sequence data
11/04/1999WO1999055369A1 Monoclonal antibodies with reduced immunogenicity
11/04/1999WO1999055367A1 INTERNALIZING ErbB2 ANTIBODIES
11/04/1999WO1999055364A2 Proteins that direct the secretion of virulence proteins and vaccines comprising them
11/04/1999WO1999055363A1 Compositions and methods for tolerization in immune complex-mediated disease progression
11/04/1999WO1999055359A1 Compositions and methods for extending the action of clostridial neurotoxin
11/04/1999WO1999055348A2 Stabilised virus preparation
11/04/1999WO1999055347A2 Treatment of papilloma virus infection using a mycobacterium
11/04/1999WO1999055312A2 Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces
11/04/1999WO1999055310A1 Stabilized protein crystals, formulations containing them and methods of making them
11/04/1999WO1999047648A3 Medium and method for viral propagation and growth
11/04/1999WO1999045104A3 Purification of virus preparations
11/04/1999WO1999043353A3 Combination anti-selectin and immunosuppressant therapy
11/04/1999WO1999042585A9 Compositions containing an ox-40 receptor binding agent or a nucleic acid encoding the same and methods for enhancing antigen-specific immune response
11/04/1999WO1999042477A8 Transporter protein for saccharide-coupled medicaments
11/04/1999WO1999037788A9 Diagnosis and treatment of aur1 and/or aur2 related disorders
11/04/1999WO1999037775A3 Compositions and methods for detecting and treating breast cancer
11/04/1999WO1999033981A3 Human signal peptide-containing proteins
11/04/1999WO1999029865A9 A protein belonging to the tnf superfamily, nucleic acids encoding same, and methods of use thereof
11/04/1999WO1999029724A9 Dna encoding pasteurella multocida outer membrane protein
11/04/1999WO1997049812A3 Process for extracting and purifying recombinant, non-lipidised osp-protein
11/04/1999CA2330476A1 Stabilized protein crystals, formulations containing them and methods of making them
11/04/1999CA2330387A1 Treatment of papilloma virus infection using a mycobacterium
11/04/1999CA2329897A1 Polysaccharide-antigen conjugates
11/04/1999CA2328111A1 Compositions and methods for extending the action of clostridial neurotoxin
11/04/1999CA2327505A1 Monoclonal antibodies with reduced immunogenicity
11/04/1999CA2327456A1 Nucleic acids of the m antigen gene of histoplasma capsulatum, antigens, vaccines and antibodies, methods and kits for detecting histoplasmosis
11/04/1999CA2327178A1 Host-encoded protein expressed on marek's disease (mdv)-infected cells and antibody thereto
11/04/1999CA2326820A1 Polypeptides from moraxella (branhamella) catarrhalis
11/04/1999CA2326755A1 G-csf receptor agonist antibodies and screening method therefor
11/04/1999CA2326404A1 Basb013 dna and proteins from neisseria meningitidis
11/04/1999CA2326377A1 Internalizing erbb2 antibodies
11/04/1999CA2326376A1 Polyepitope carrier protein
11/04/1999CA2326375A1 Basb006 polynucleotide(s) and polypeptides from neisseria meningitis
11/04/1999CA2326001A1 Fizz proteins
11/04/1999CA2325055A1 Vaccines containing recombinant pilin against neisseria gonorrhoeae or neisseria meningitidis
11/03/1999EP0953648A2 Viral defective vaccine produced by transcomplementing cell line
11/03/1999EP0953642A1 Antigenic protein originating in infectious laryngotracheitis virus
11/03/1999EP0953641A2 Polynucleotide molecules encoding neospora proteins
11/03/1999EP0953639A1 FAPalpha-specific antibody with improved producibility
11/03/1999EP0953637A2 Acetylcholine receptor
11/03/1999EP0953351A2 Medicaments containing, as the main ingredient, allogenic activated-CD4+ cells and method for producing the same
11/03/1999EP0953153A1 Novel method of diagnosing and treating gliomas
11/03/1999EP0953048A1 Compounds for modulating cell negative regulations and biological applications thereof
11/03/1999EP0953047A2 VACCINE CONTAINING A PEROXIREDOXIN AND/OR A beta-TUBULIN
11/03/1999EP0953038A1 Novel process for the propagation of b. pertussis
11/03/1999EP0952985A1 Broad spectrum pyrogenic exotoxins antagonists and vaccines
11/03/1999EP0952984A1 Two-component signal tranducing system from staphylococcus aureus
11/03/1999EP0952982A2 Novel hepatitis b inhibitors
11/03/1999EP0952849A1 Early detection of mycobacterial disease
11/03/1999EP0952848A2 Anti-allergenic compound
11/03/1999EP0952846A1 Prolactin as a vaccine adjuvant
11/03/1999EP0952771A1 Novel saponin compositions and uses thereof
11/03/1999EP0754058B1 Wound healing
11/03/1999EP0639081B1 Vaccine compositions for mucosal delivery
11/03/1999EP0371998B2 Modular assembly of antibody genes, antibodies prepared thereby and use
11/03/1999EP0362279B2 Saponin adjuvant
11/03/1999CN1234118A Material and method relating to diagnosis and treatment of diabetes and obesity
11/03/1999CN1234078A Compositions and method for treating viral infections
11/03/1999CN1234072A Anti-ErbB2 antibodies
11/03/1999CN1233504A Method for preparing medicine for treating malignant tumor by using staphylococcus aureus supraantigen as raw material
11/02/1999US5977339 Methods and compositions for diagnosing lyme disease
11/02/1999US5977337 The nucleic acid molecule may be used in the diagnosis of infection.
11/02/1999US5977336 High molecular weight surface proteins of non-typeable haemophilus
11/02/1999US5977316 Antiidiotypic antibody which induces immune response to ganglioside gd2; anticarcinogenic/antitumor agents against melanoma, neuroblastoma, glioma, soft tissue sarcoma, and small cell carcinoma; for decreasing the risk of recurrence
11/02/1999US5977315 Murine anti-idiotype antibody 3H1
11/02/1999US5977314 Catalytic antibodies against cocaine
11/02/1999US5977311 53BP2 complexes
11/02/1999US5977300 Isolated nonapeptide which bind to HLA-B44 molecules and the uses thereof
11/02/1999US5977299 Peptide having terminal activating group; for sensitive diagnostics; therapy
11/02/1999US5977085 Vectors carrying coding sequence for the SpsB protein of Staphylococcus aureus
11/02/1999US5977081 Triterpene saponin analogs having adjuvant and immunostimulatory activity
11/02/1999US5976864 Expression and secretion of heterologous polypeptides from caulobacter
11/02/1999US5976862 Process for obtaining DNA, RNA, peptides, polypeptides, or proteins, by recombinant DNA technique
11/02/1999US5976860 Cell lines infected with granulocytic ehrlichia, vaccines, diagnostics and methods
11/02/1999US5976840 Polynucleotides encoding gluS polypeptides of streptococcal pneumoniae
11/02/1999US5976839 Plasmid for production of fusion protein of immunogen and peptide carrier from an escherichia coli membrane protein; enhanced immune response in host regardless of whether protein is administered parenterally, orally, or enterally
11/02/1999US5976834 cDNA clone HNFJD15 that encodes a novel human 7-transmembrane receptor
11/02/1999US5976814 DNA encoding a human neuropeptide Y/peptide YY/pancreatic polypeptide receptor (Y4) and uses thereof
11/02/1999US5976785 Competitive assays for determining the effectiveness of a human immunodeficiency virus type 2 (HIV-2) antiviral agent, employing peptides and proteins of HIV-2
11/02/1999US5976580 Mixture of water, carbonhydrates, amino acid and adjuvants; supplying nutrients during hatching, traveling
11/02/1999US5976552 Virus vaccines
11/02/1999US5976546 Antigen presenting cells activated by contact with a polypeptide complex constructed by joining together a dendritic cell-binding protein and a polypeptide antigen.
11/02/1999US5976545 ZPC polypeptides
11/02/1999US5976544 Polypeptides and vaccines for Bordetellapertussis and method of use
11/02/1999US5976542 Bacterial enzymes as targets for antibiotic therapy and as bacterial vaccines.
1 ... 1508 1509 1510 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 ... 1823